152 related articles for article (PubMed ID: 12518020)
1. Cholesteryl ester transfer protein expression attenuates atherosclerosis in ovariectomized mice.
Cazita PM; Berti JA; Aoki C; Gidlund M; Harada LM; Nunes VS; Quintão EC; Oliveira HC
J Lipid Res; 2003 Jan; 44(1):33-40. PubMed ID: 12518020
[TBL] [Abstract][Full Text] [Related]
2. Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression.
Plump AS; Masucci-Magoulas L; Bruce C; Bisgaier CL; Breslow JL; Tall AR
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1105-10. PubMed ID: 10195942
[TBL] [Abstract][Full Text] [Related]
3. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
Westerterp M; van der Hoogt CC; de Haan W; Offerman EH; Dallinga-Thie GM; Jukema JW; Havekes LM; Rensen PC
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130
[TBL] [Abstract][Full Text] [Related]
4. Atherosclerosis is enhanced by testosterone deficiency and attenuated by CETP expression in transgenic mice.
Casquero AC; Berti JA; Salerno AG; Bighetti EJ; Cazita PM; Ketelhuth DF; Gidlund M; Oliveira HC
J Lipid Res; 2006 Jul; 47(7):1526-34. PubMed ID: 16603720
[TBL] [Abstract][Full Text] [Related]
5. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein.
Marotti KR; Castle CK; Boyle TP; Lin AH; Murray RW; Melchior GW
Nature; 1993 Jul; 364(6432):73-5. PubMed ID: 8316302
[TBL] [Abstract][Full Text] [Related]
6. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice.
Föger B; Chase M; Amar MJ; Vaisman BL; Shamburek RD; Paigen B; Fruchart-Najib J; Paiz JA; Koch CA; Hoyt RF; Brewer HB; Santamarina-Fojo S
J Biol Chem; 1999 Dec; 274(52):36912-20. PubMed ID: 10601244
[TBL] [Abstract][Full Text] [Related]
7. Effect of CETP on the plasma lipoprotein profile in four strains of transgenic mouse.
Takahashi H; Takahashi A; Maki M; Sasai H; Kamada M
Biochem Biophys Res Commun; 2001 Apr; 283(1):118-23. PubMed ID: 11322777
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice.
Berti JA; Amaral ME; Boschero AC; Nunes VS; Harada LM; Castilho LN; Oliveira HC
Metabolism; 2001 May; 50(5):530-6. PubMed ID: 11319713
[TBL] [Abstract][Full Text] [Related]
9. Soy protein containing isoflavones favorably influences macrophage lipoprotein metabolism but not the development of atherosclerosis in CETP transgenic mice.
Asakura L; Cazita PM; Harada LM; Nunes VS; Berti JA; Salerno AG; Ketelhuth DF; Gidlund M; Oliveira HC; Quintão EC
Lipids; 2006 Jul; 41(7):655-62. PubMed ID: 17069349
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia.
Le Goff W; Guerin M; Chapman MJ
Pharmacol Ther; 2004 Jan; 101(1):17-38. PubMed ID: 14729390
[TBL] [Abstract][Full Text] [Related]
11. Effect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits.
Sugano M; Makino N; Sawada S; Otsuka S; Watanabe M; Okamoto H; Kamada M; Mizushima A
J Biol Chem; 1998 Feb; 273(9):5033-6. PubMed ID: 9478952
[TBL] [Abstract][Full Text] [Related]
12. Cholesteryl ester transfer protein: an enigmatic protein.
Moulin P
Horm Res; 1996; 45(3-5):238-44. PubMed ID: 8964591
[TBL] [Abstract][Full Text] [Related]
13. Cholesteryl ester transfer protein expression prevents diet-induced atherosclerotic lesions in male db/db mice.
MacLean PS; Bower JF; Vadlamudi S; Osborne JN; Bradfield JF; Burden HW; Bensch WH; Kauffman RF; Barakat HA
Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1412-5. PubMed ID: 12791674
[TBL] [Abstract][Full Text] [Related]
14. Elevation of plasma phospholipid transfer protein increases the risk of atherosclerosis despite lower apolipoprotein B-containing lipoproteins.
Lie J; de Crom R; van Gent T; van Haperen R; Scheek L; Sadeghi-Niaraki F; van Tol A
J Lipid Res; 2004 May; 45(5):805-11. PubMed ID: 14993244
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein CI deficiency markedly augments plasma lipoprotein changes mediated by human cholesteryl ester transfer protein (CETP) in CETP transgenic/ApoCI-knocked out mice.
Gautier T; Masson D; Jong MC; Duverneuil L; Le Guern N; Deckert V; Pais de Barros JP; Dumont L; Bataille A; Zak Z; Jiang XC; Tall AR; Havekes LM; Lagrost L
J Biol Chem; 2002 Aug; 277(35):31354-63. PubMed ID: 12070157
[TBL] [Abstract][Full Text] [Related]
16. Important role for bone marrow-derived cholesteryl ester transfer protein in lipoprotein cholesterol redistribution and atherosclerotic lesion development in LDL receptor knockout mice.
Van Eck M; Ye D; Hildebrand RB; Kar Kruijt J; de Haan W; Hoekstra M; Rensen PC; Ehnholm C; Jauhiainen M; Van Berkel TJ
Circ Res; 2007 Mar; 100(5):678-85. PubMed ID: 17293475
[TBL] [Abstract][Full Text] [Related]
17. Cholesteryl ester transfer protein: pharmacological inhibition for the modulation of plasma cholesterol levels and promising target for the prevention of atherosclerosis.
Ruggeri RB
Curr Top Med Chem; 2005; 5(3):257-64. PubMed ID: 15857309
[TBL] [Abstract][Full Text] [Related]
18. Oxidation of LDL enhances the cholesteryl ester transfer protein (CETP)-mediated cholesteryl ester transfer rate to HDL, bringing on a diminished net transfer of cholesteryl ester from HDL to oxidized LDL.
Castilho LN; Oliveira HC; Cazita PM; de Oliveira AC; Sesso A; Quintão EC
Clin Chim Acta; 2001 Feb; 304(1-2):99-106. PubMed ID: 11165204
[TBL] [Abstract][Full Text] [Related]
19. Alterations in composition and concentration of lipoproteins and elevated cholesteryl ester transfer in non-insulin-dependent diabetes mellitus (NIDDM).
Elchebly M; Porokhov B; Pulcini T; Berthezène F; Ponsin G
Atherosclerosis; 1996 Jun; 123(1-2):93-101. PubMed ID: 8782840
[TBL] [Abstract][Full Text] [Related]
20. Action of atorvastatin in combined hyperlipidemia : preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles.
Guerin M; Lassel TS; Le Goff W; Farnier M; Chapman MJ
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):189-97. PubMed ID: 10634817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
